BDBM562109 N-Methyl-2-[2-(3-methylimidazol-4-yl)-4-quinolyl]-1-(2-oxo-3,4-dihydro-1H-quinolin-6-yl)benzimidazole-5-carboxamide::US11401256, Example 2

SMILES CNC(=O)c1ccc2n(c(nc2c1)-c1cc(nc2ccccc12)-c1cncn1C)-c1ccc2NC(=O)CCc2c1

InChI Key InChIKey=QXGJZPQVKZRAFS-UHFFFAOYSA-N

Data  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 562109   

TargetProtein cereblon(Human)
C4 Therapeutics

US Patent
LigandPNGBDBM562109(US11401256, Example 2 | N-Methyl-2-[2-(3-methylimi...)
Affinity DataKd:  40nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
In DepthDetails
US Patent